ArticleFrontiers in oncology2022

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.